Table 1B.
Characteristics of incident cancer patients treated with epoetin or transfusion classified by sequence of treatment
| Epoetins onlyn = 2649 | Transfusions onlyn = 62 853 | Epoetins before transfusionsn = 1488 | Transfusions before epoetinsn = 2851 | Transfusions and epoetinsn = 47 | |
|---|---|---|---|---|---|
| Median age at cohort entry (Q1, Q3) | 60 (49, 69) | 70 (59, 79) | 65 (55, 71) | 66 (58, 73) | 64 (54, 69) |
| Assessment of cancer | |||||
| Via diagnoses only | 426 (16.1%) | 46 019 (73.2%) | 305 (20.5%) | 1727 (60.6%) | 4 (8.5%) |
| Via diagnoses and therapy | 2109 (79.6%) | 16 193 (25.8%) | 1144 (76.9%) | 1053 (36.9%) | 41 (87.2%) |
| Via therapy only | 114 (4.3%) | 641 (1.0%) | 39 (2.6%) | 71 (2.5%) | 2 (4.3%) |
| Cancer with unfavourable prognosis * | 357 (13.5%) | 15 850 (25.2%) | 472 (31.7%) | 695 (24.4%) | 22 (46.8%) |
| Chronic kidney disease | 507 (19.1%) | 11 672 (18.6%) | 360 (24.2%) | 918 (32.2%) | 4 (8.5%) |
| Median value of CCI ** (Q1, Q3) | 5 (2, 9) | 6 (3, 9) | 8 (4, 9) | 8 (4, 9) | 8 (4, 10) |